Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone. (Record no. 6376736)

MARC details
000 -LEADER
fixed length control field 01649 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512211908.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198408s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0022-5347
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0022-5347(17)49582-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kurth, K H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19840823
245 00 - TITLE STATEMENT
Title Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Journal of urology
Date of publication, distribution, etc. Aug 1984
300 ## - PHYSICAL DESCRIPTION
Extent 258-62 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Transitional Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ethers
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ethoglucid
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Random Allocation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Urethra
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Urinary Bladder Neoplasms
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schröder, F H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tunn, U
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ay, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pavone-Macaluso, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Debruyne, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de Pauw, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dalesio, O
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name ten Kate, F
773 0# - HOST ITEM ENTRY
Title The Journal of urology
Related parts vol. 132
-- no. 2
-- p. 258-62
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0022-5347(17)49582-6">https://doi.org/10.1016/s0022-5347(17)49582-6</a>
Public note Available from publisher's website

No items available.